Researchers combined protein biomarkers, cfDNA analysis, and machine learning to open opportunities for early-stage ovarian cancer screening and diagnostics. The cfDNA fragmentome is a genome-wide ...
Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad range of cancers with high accuracy using cell-free DNA. A multi-cancer early ...
News Medical on MSN
Novel liquid biopsy technology lowers barriers for more efficient cancer diagnostics
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...
A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to treatment with immune checkpoint inhibitor drugs, investigators at the Johns ...
Androgen pathway gene expression and response to hormonal therapy in prostate cancer (SWOG S1216). This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include ...
A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...
3hon MSNOpinion
National genomic screening program could save thousands of Australians from preventable cancer and heart disease
Leading genomic health experts from Monash University are calling for urgent government funding to progress the development ...
When cells in the body die, they release DNA. This DNA, known as cell-free DNA (cfDNA), makes its way into the bloodstream where it gets chopped up by enzymes, and in minutes to hours, the liver pulls ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback